Caligan Partners LP → STANDARD BIOTOOLS INC. LAB

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

3 transactions

3 buys · 0 sales · 0 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 5.59

10,319,954 shares short · +24.6% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $183K

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-03-20	Egholm Michael	director, officer	Award	1,042,373	—	—
2026-03-20	Mackay Sean	officer	Award	272,107	—	—
2026-03-20	Kim Hanjoon Alex	officer	Award	323,173	—	—

Other 13D/G Filings on STANDARD BIOTOOLS INC.

Filed	Form	Filer	Stake	Shares
2025-03-04	SCHEDULE	Casdin Capital, LLC	21.60%	80,864,315	view →
2024-01-09	SC	Casdin Capital, LLC	—	—	view →
2023-07-03	SC	Caligan Partners LP	—	—	view →
2018-03-06	SC	LEVIN CAPITAL STRATEGIES, L.P.	—	—	view →
2018-01-11	SC	LEVIN CAPITAL STRATEGIES, L.P.	—	—	view →

Other Filings by Caligan Partners LP

Filed	Form	Issuer	Stake	Shares
2026-01-27	SCHEDULE	Anika Therapeutics, Inc. ANIK	9.95%	1,435,130	view →
2023-07-03	SC	STANDARD BIOTOOLS INC. LAB	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →